Kirill Kiselyov

7PUBLICATIONS
19CO-AUTHORS
Molecular targetsPredictive and prognostic markersCreative arts, media and communication curriculum and pedagogyChemotherapyEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 08, 2025
Epidrug screening identifies type I PRMT inhibitors as modulators of lysosomal exocytosis and drug sensitivity in cancers.

Baris Sergi, Neslihan Yuksel-Catal, Selahattin Can Ozcan

|Dec 19, 2024
Lysosomal-Mitochondrial Interaction Promotes Tumor Growth in Squamous Cell Carcinoma of the Head and Neck.

Avani Gopalkrishnan, Nathaniel Wang, Silvia Cruz-Rangel

|Apr 25, 2024
Peer-reviewed presentation exchange in an undergraduate classroom.

Kirill Kiselyov, Christian D Schunn

|Sep 05, 2022
Storytelling as a Tool to Enhance Conceptual Knowledge in Cell Biology.

Kirill Kiselyov, Christian D Schunn

|Mar 14, 2022
Lysosomal inhibition sensitizes TMEM16A-expressing cancer cells to chemotherapy.

Avani Vyas, Roberto Gomez-Casal, Silvia Cruz-Rangel

|Aug 16, 2021
Evolutionary rate covariation identifies SLC30A9 (ZnT9) as a mitochondrial zinc transporter.

Amanda Kowalczyk, Omotola Gbadamosi, Kathryn Kolor

Pageof 2